Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caracciolo

Showing results (841-850 of 982) with videos related to

Pageof 99
Sort By:
Journal of Cellular Physiology|December 7, 2018
Nanoparticle-biomolecular corona: A new approach for the early detection of non-small-cell lung cancerMarina Di Domenico, Daniela Pozzi, Sara Palchetti, et al.
Nature Communications|April 3, 2020
Author Correction: Interplay of protein corona and immune cells controls blood residency of liposomesFrancesca Giulimondi, Luca Digiacomo, Daniela Pozzi, et al.
Nature Communications|August 3, 2021
Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopeniaM De Michele, M Iacobucci, A Chistolini, et al.
British Journal of Haematology|December 8, 2011
Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio LinfomiFrancesco Merli, Stefano Luminari, Fiorella Ilariucci, et al.
Annali Italiani Di Chirurgia|August 24, 2010
[Prognostic and curative value of sentinel node in breast cancer. A 377 patients experience]Carlo Iannace, Lorenzo Di Libero, Maria Lepore, et al.
Plos One|March 4, 2014
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cellsMaria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, et al.
American Journal of Hematology|November 16, 2012
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patientsBarbara Scappini, Giacomo Gianfaldoni, Francesco Caracciolo, et al.
Plos Computational Biology|March 31, 2021
CODON-Software to manual curation of prokaryotic genomesBruno Merlin, Jorianne Thyeska Castro Alves, Pablo Henrique Caracciolo Gomes de Sá, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 9, 2026
Excellent outcomes of living donor liver transplantation: A contemporary report from Western CenterStefano Di Sandro, Barbara Catellani, Roberta Odorizzi, et al.
Leukemia|December 26, 2001
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphomaM Ladetto, F Zallio, S Vallet, et al.
Pageof 99

Showing results (841-850 of 982) with videos related to

Sort By:
Pageof 99
Journal of Cellular Physiology|December 7, 2018
Nanoparticle-biomolecular corona: A new approach for the early detection of non-small-cell lung cancerMarina Di Domenico, Daniela Pozzi, Sara Palchetti, et al.
Nature Communications|April 3, 2020
Author Correction: Interplay of protein corona and immune cells controls blood residency of liposomesFrancesca Giulimondi, Luca Digiacomo, Daniela Pozzi, et al.
Nature Communications|August 3, 2021
Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopeniaM De Michele, M Iacobucci, A Chistolini, et al.
British Journal of Haematology|December 8, 2011
Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio LinfomiFrancesco Merli, Stefano Luminari, Fiorella Ilariucci, et al.
Annali Italiani Di Chirurgia|August 24, 2010
[Prognostic and curative value of sentinel node in breast cancer. A 377 patients experience]Carlo Iannace, Lorenzo Di Libero, Maria Lepore, et al.
Plos One|March 4, 2014
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cellsMaria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, et al.
American Journal of Hematology|November 16, 2012
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patientsBarbara Scappini, Giacomo Gianfaldoni, Francesco Caracciolo, et al.
Plos Computational Biology|March 31, 2021
CODON-Software to manual curation of prokaryotic genomesBruno Merlin, Jorianne Thyeska Castro Alves, Pablo Henrique Caracciolo Gomes de Sá, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 9, 2026
Excellent outcomes of living donor liver transplantation: A contemporary report from Western CenterStefano Di Sandro, Barbara Catellani, Roberta Odorizzi, et al.
Leukemia|December 26, 2001
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphomaM Ladetto, F Zallio, S Vallet, et al.
Pageof 99